349 related articles for article (PubMed ID: 25844615)
21. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Mehta RC; Garruto J; Gotz V; Sigler ML; Herndon JH
J Drugs Dermatol; 2013 Mar; 12(3):s21-6. PubMed ID: 23545929
[TBL] [Abstract][Full Text] [Related]
22. A novel, volumizing cosmetic formulation significantly improves the appearance of target Glabellar lines, nasolabial folds, and crow's feet in a double-blind, vehicle-controlled clinical trial.
Farris PK; Edison BL; Weinkauf RL; Green BA
J Drugs Dermatol; 2014 Jan; 13(1):41-6. PubMed ID: 24385118
[TBL] [Abstract][Full Text] [Related]
23. A clinical study of topical Pyratine 6 for improving the appearance of photodamaged skin.
McCullough JL; Garcia RL; Reece B
J Drugs Dermatol; 2008 Feb; 7(2):131-5. PubMed ID: 18335649
[TBL] [Abstract][Full Text] [Related]
24. A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen.
Fu JJ; Hillebrand GG; Raleigh P; Li J; Marmor MJ; Bertucci V; Grimes PE; Mandy SH; Perez MI; Weinkle SH; Kaczvinsky JR
Br J Dermatol; 2010 Mar; 162(3):647-54. PubMed ID: 20374604
[TBL] [Abstract][Full Text] [Related]
25. A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
Kang S; Krueger GG; Tanghetti EA; Lew-Kaya D; Sefton J; Walker PS; Gibson JR;
J Am Acad Dermatol; 2005 Feb; 52(2):268-74. PubMed ID: 15692472
[TBL] [Abstract][Full Text] [Related]
26. An Open Label Clinical Trial to Evaluate the Efficacy and Tolerance of a Retinol and Vitamin C Facial Regimen in Women With Mild-to-Moderate Hyperpigmentation and Photodamaged Facial Skin.
Herndon JH; Jiang LI; Kononov T; Fox T
J Drugs Dermatol; 2016 Apr; 15(4):476-82. PubMed ID: 27050703
[TBL] [Abstract][Full Text] [Related]
27. Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
Lowe N; Gifford M; Tanghetti E; Poulin Y; Goldman M; Tse Y; Yamauchi P; Rosenzweig H; Kang S
J Cosmet Laser Ther; 2004 Jun; 6(2):79-85. PubMed ID: 15203997
[TBL] [Abstract][Full Text] [Related]
28. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Herndon JH; Sigler ML; Gotz V; Garruto J; Mehta RC
J Drugs Dermatol; 2012 Dec; 11(12):1478-82. PubMed ID: 23377519
[TBL] [Abstract][Full Text] [Related]
29. A double-blind randomized study comparing the association of Retinol and LR2412 with tretinoin 0.025% in photoaged skin.
Bouloc A; Vergnanini AL; Issa MC
J Cosmet Dermatol; 2015 Mar; 14(1):40-6. PubMed ID: 25603890
[TBL] [Abstract][Full Text] [Related]
30. 4-Hexyl-1,3-phenylenediol, a nuclear factor-κB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial.
Kaur S; Kizoulis M; Fantasia J; Oddos T; Bigot N; Galera P; Tucker-Samaras S; Leyden JJ; Southall MD
Br J Dermatol; 2015 Jul; 173(1):218-26. PubMed ID: 25752195
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
Bruce S
J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
[TBL] [Abstract][Full Text] [Related]
32. Reduction in facial photodamage by a topical growth factor product.
Mehta RC; Smith SR; Grove GL; Ford RO; Canfield W; Donofrio LM; Flynn TC; Leyden JJ
J Drugs Dermatol; 2008 Sep; 7(9):864-71. PubMed ID: 19112801
[TBL] [Abstract][Full Text] [Related]
33. Facial primer provides immediate and long-term improvements in mild-to-moderate facial hyperpigmentation and fine lines associated with photoaging.
Roberts WE; Jiang LI; Herndon JH
Clin Cosmet Investig Dermatol; 2015; 8():471-7. PubMed ID: 26366102
[TBL] [Abstract][Full Text] [Related]
34. Treatment of photoaged skin with a cream containing 0.05% isotretinoin and sunscreens.
Griffiths CE; Maddin S; Wiedow O; Marks R; Donald AE; Kahlon G
J Dermatolog Treat; 2005 Apr; 16(2):79-86. PubMed ID: 16019621
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of two commercial hyperpigmentation kits in the treatment of facial hyperpigmentation and photo-aging.
Fabi S; Massaki N; Goldman MP
J Drugs Dermatol; 2012 Aug; 11(8):964-8. PubMed ID: 22859242
[TBL] [Abstract][Full Text] [Related]
36. Enhanced efficacy of a topical antioxidants regimen in conjunction with a home-use non-ablative fractional diode laser in photodamaged facial skin.
Geronemus R; Du A; Yatskayer M; Lynch S; Krol Y; Oresajo C
J Cosmet Laser Ther; 2016 Jun; 18(3):154-61. PubMed ID: 26727154
[TBL] [Abstract][Full Text] [Related]
37. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin. A double-blind vehicle-controlled clinical trial.
Stiller MJ; Bartolone J; Stern R; Smith S; Kollias N; Gillies R; Drake LA
Arch Dermatol; 1996 Jun; 132(6):631-6. PubMed ID: 8651713
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of the effect of a topical product containing salicin on the visible signs of human skin aging.
Gopaul R; Knaggs HE; Lephart JF; Holley KC; Gibson EM
J Cosmet Dermatol; 2010 Sep; 9(3):196-201. PubMed ID: 20883292
[TBL] [Abstract][Full Text] [Related]
39. A stabilized 0.1% retinol facial moisturizer improves the appearance of photodamaged skin in an eight-week, double-blind, vehicle-controlled study.
Tucker-Samaras S; Zedayko T; Cole C; Miller D; Wallo W; Leyden JJ
J Drugs Dermatol; 2009 Oct; 8(10):932-6. PubMed ID: 19852122
[TBL] [Abstract][Full Text] [Related]
40. Topical retinoids in the management of photodamaged skin: from theory to evidence-based practical approach.
Darlenski R; Surber C; Fluhr JW
Br J Dermatol; 2010 Dec; 163(6):1157-65. PubMed ID: 20633013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
